Unraveling the potential clinical utility of circulating tumor DNA detection in colorectal cancer—evaluation in a nationwide Danish cohortTenna Vesterman Henriksen, Claus L. Andersen, Christina Demuth et al.|Annals of Oncology|2023Cited by 71
Increased PD-L1 expression in erlotinib-resistant NSCLC cells with <i>MET</i> gene amplification is reversed upon MET-TKI treatmentChristina Demuth, Boe Sandahl Sørensen|Oncotarget|2017Cited by 35
Impact of Whole Genome Doubling on Detection of Circulating Tumor DNA in Colorectal CancerJonas Kabel, Claus L. Andersen, Christina Demuth et al.|Cancers|2023Cited by 12
DREAMS: deep read-level error model for sequencing data applied to low-frequency variant calling and circulating tumor DNA detectionMikkel Hovden Christensen, Jakob Skou Pedersen, Simon Opstrup Drue et al.|Genome biology|2023Cited by 12
Circulating tumour DNA and risk of recurrence in patients with asymptomatic versus symptomatic colorectal cancerNadia Øgaard, Claus L. Andersen, Sarah Østrup Jensen et al.|British Journal of Cancer|2024Cited by 10